F/M Emerald Life Sciences Innovation ETF (LFSC)
NASDAQ: LFSC · Real-Time Price · USD
40.17
+0.45 (1.12%)
Jun 12, 2026, 4:00 PM EDT - Market closed
LFSC Holdings Information
LFSC is an equity ETF with a total of 41 individual holdings. The top holdings are Travere Therapeutics stock at 7.76%, LivaNova at 7.71%, Cogent Biosciences at 6.90%, Spyre Therapeutics at 6.69%, and Guardant Health at 5.68%.
Total Holdings
41
Top 10 Percentage
55.49%
Asset Class
Equity
ETF Category
Health
Assets
108.34M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TVTX | Travere Therapeutics, Inc. | 7.76% |
| 2 | LIVN | LivaNova PLC | 7.71% |
| 3 | COGT | Cogent Biosciences, Inc. | 6.90% |
| 4 | SYRE | Spyre Therapeutics, Inc. | 6.69% |
| 5 | GH | Guardant Health, Inc. | 5.68% |
| 6 | CORT | Corcept Therapeutics Incorporated | 5.50% |
| 7 | MIRM | Mirum Pharmaceuticals, Inc. | 4.65% |
| 8 | UTHR | United Therapeutics Corporation | 4.15% |
| 9 | SVRA | Savara Inc. | 3.22% |
| 10 | MANE | Veradermics, Incorporated | 3.22% |
| 11 | AXSM | Axsome Therapeutics, Inc. | 3.05% |
| 12 | TMDX | TransMedics Group, Inc. | 3.05% |
| 13 | TRVI | Trevi Therapeutics, Inc. | 3.02% |
| 14 | CYTK | Cytokinetics, Incorporated | 2.82% |
| 15 | NKTR | Nektar Therapeutics | 2.81% |
| 16 | BLLN | BillionToOne, Inc. | 2.80% |
| 17 | DNTH | Dianthus Therapeutics, Inc. | 2.59% |
| 18 | ICUI | ICU Medical, Inc. | 2.21% |
| 19 | VRDN | Viridian Therapeutics, Inc. | 2.04% |
| 20 | CRVS | Corvus Pharmaceuticals, Inc. | 1.79% |
| 21 | PVLA | Palvella Therapeutics, Inc. | 1.71% |
| 22 | CBLL | CeriBell, Inc. | 1.58% |
| 23 | XERS | Xeris Biopharma Holdings, Inc. | 1.35% |
| 24 | GMED | Globus Medical, Inc. | 1.28% |
| 25 | BBIO | BridgeBio Pharma, Inc. | 1.21% |
As of Jun 10, 2026